In this study we have developed two gene-specific in vitro assays to examine the capacity of food to affect variants of SLC22A4 and IL-10 that are associated with IBD and validated these with responses with known active compounds (ET and DEXA, respectively) [18,40]. The gene discussed is SLC22A4; the disease is inflammatory bowel disease.